Diamonds and Dogs
An upgrade for drug maker, AbbVie (ABBV). ABBVie is up 2% to a three-month high after the analyst at Citigroup upgraded the stock with a $90 price target, 20% above current levels. The analyst expects the pending acquisition of Allergan and better prospects for AbbVie's drugs, Skyrizi and Rinvoq to give the stock a boost and a catalyst to move higher going forward. The analyst previously had a sell rating on the stock.
Carnival (CCL) can't get out of its own way. The cruise operator is down 8% to back near its 52 week low after cutting its 2019 profit forecast for the third time this year. The company is blaming higher fuel prices, yet the price of oil is not far from its lows for the year. Fuel, a large part of cruise operators' operating costs, accounted for about 11.4% of Carnival's total operating expense. An attacked on Saudi Arabia a few weeks ago caused the price of oil to spike. A bigger problem may be the tensions on the Middle East impacting recent booking trends and ticket prices. A global economic slowdown isn't helping things as well.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.